Page last updated: 2024-08-23

amikacin and Ovarian Neoplasms

amikacin has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barner, K; Behbakht, K; Bitler, BG; Hicks, D; Jansson, T; Powell, T; Qamar, L; Ramzan, AA; Wilson, H	1

Other Studies

1 other study(ies) available for amikacin and Ovarian Neoplasms

Article	Year
Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells. Molecular and cellular biochemistry, 2019, Volume: 461, Issue:1-2 Topics: AMP-Activated Protein Kinases; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Mitosis; Models, Biological; Neoplasm Grading; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Piperidines; Receptors, Adiponectin	2019

Article

Year

Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.

Molecular and cellular biochemistry, 2019, Volume: 461, Issue:1-2

Topics: AMP-Activated Protein Kinases; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Mitosis; Models, Biological; Neoplasm Grading; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Piperidines; Receptors, Adiponectin

2019